Page 20 - Simulations Plus News Today

Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Simulations Plus, inc (NASDAQ: SLP) Q3 2021 Earnings Call Operator Greetings and welcome to the Simulations Plus Third Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Brian Siegel from Hayden IR. Thank you Mr. Siegel. ...

Drug modeling software company Simulations Plus Inc. beat analyst estimates for its second fiscal quarter, with net income increasing a whopping 49 percent. The Lancaster-based company, which makes a platform used by the pharmaceutical industry for drug research and development, reported an adjusted net income of $3.2 million (15 cents a share) for the quarter ended Feb. 28, compared to adjusted net income of $2.15 million (12 cents) for the same quarter a year ago. Revenue increased 27 percent...

Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Simulations Plus Inc (NASDAQ: SLP) Popular Searches Operator Greetings and welcome to Simulations Plus Second Quarter Fiscal 2021 Financial Results Conference Call and Webinar. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a...

Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth...

Here’s Why Conestoga Capital Advisors Sold Proto Labs Inc. (PRLB) Conestoga Capital Advisors, a boutique, independent investment management firm, published its fourth-quarter 2020 ‘Small Cap Growth & SMid Cap Growth’ Investor Letter – a copy of which can be downloaded here. A net return of 31% was recorded by Conestoga’s Small Cap Growth fund and 19.72% return by its SMid Cap Growth Fund for the the end year 2020. Both performed below their Russell 2000 Growth and Russell 2500 Growth...

Press release content from Business Wire. The AP news staff was not involved in its creation. Simulations Plus Enters Agreement with Distributor in China February 2, 2021 GMT LANCASTER, Calif.--(BUSINESS WIRE)--Feb 2, 2021-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has entered into a distribution agreement with Mosim, one of China’s leadi...

The recent report on “Global Molecular Modelling Market Report by Key Players, Types, Applications, Market Size, Market Share, Regions and  Forecast to 2027” offered by Data bridge market research covers various industry dynamics and tendencies that helps in the market growth.Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Molecular Modelling Market”. The research report also offers the lates...

25 The recent report on “Global Molecular Modelling Market Report by Key Players, Types, Applications, Market Size, Market Share, Regions and  Forecast to 2027” offered by Data bridge market research covers various industry dynamics and tendencies that helps in the market growth.Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Molecular Modelling Market”. The research report also offers the l...

Press release content from Business Wire. The AP news staff was not involved in its creation. Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics January 14, 2021 GMT LANCASTER, Calif.--(BUSINESS WIRE)--Jan 14, 2021-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen division has awarded a grant to th...

First quarter revenue of $10.7 million, reflecting 14% year-over-year growthBoard of Directors announces quarterly dividend of $0.06 per shareLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemic...